Akanda (AKAN) Other Non-Current Assets (2022 - 2025)

Akanda's (AKAN) quarterly Other Non-Current Assets came in at $3.8 million in Q4 2025, up 264.22% year-on-year from $1.1 million in Q4 2024, and up 264.22% quarter-over-quarter from $1.1 million in Q4 2024.

Akanda (AKAN) Other Non-Current Assets (2022 - 2025) Analysis & Trends

Akanda's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $3.8 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 264.22% year-over-year to $3.8 million in Q4 2025; TTM through Dec 2025 was $3.8 million, a 264.22% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 264.22% from the prior year.
  • Other Non-Current Assets grew to $3.8 million in Q4 2025 per AKAN's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $7.4 million in Q4 2023 and bottomed at $819376.0 in Q4 2022.
  • The 4-year median for Other Non-Current Assets is $2.4 million (2024), against an average of $3.3 million.
  • Across the five-year window, Other Non-Current Assets soared 805.73% in 2023 and sank 85.82% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $819376.0 in 2022, then surged by 805.73% to $7.4 million in 2023, then sank by 85.82% to $1.1 million in 2024, then jumped by 264.22% to $3.8 million in 2025.
  • Per Business Quant, the three latest AKAN Other Non-Current Assets figures stand at $3.8 million (Q4 2025), $1.1 million (Q4 2024), and $7.4 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Akanda 556,353.85 556,353.85 - 3.83 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.83 Mn
Dec 31, 2024 1.05 Mn
Dec 31, 2023 7.42 Mn
Dec 31, 2022 819,376.00